教育和工作经历

• 2021/02-至今， 复旦大学，材料科学系，青年副研究员

• 2019/03-2021/01，同济大学，医学院，博士后

• 2013/09-2019/01，华东师范大学，生命科学学院，博士学位

• 2009/09-2013/06，西北农林科技大学，动物科技学院，学士学位

研究方向

• 1.新型无机非金属材料的合成及其抗肿瘤应用研究;

• 2.新型功能材料用于肝脏代谢类疾病研究。

学术论文

1. Yang Liu, Shaojie Zhai, Xingwu Jiang*, Yanyan Liu, Kun Wang, Chaochao Wang, Meng Zhang, Xuanyong Liu*, Wenbo Bu*. Intracellular mutual promotion of redox homeostasis regulation and iron metabolism disruption for enduring chemodynamic therapy. [J]. Advanced Functional Materials, 2021, 2010390.

2. Yifei Yin^#, Xingwu Jiang^#, Liping Sun^#, Hongyan Li, Chunxia Su, Yan Zhang, Guang Xu, Xiaolong Li, Chongke Zhao, Yu Chen^*, Huixiong Xu^*, Kun Zhang^*. Continuous inertial cavitation evokes massive ROS for reinforcing sonodynamic therapy and immunogenic cell death against breast carcinoma[J]. Nano Today, 2021, 36: 101009.

3.BeiEr Jiang^#, Xingwu Jiang^#, Qiansen Zhang, Qiuwen Liang, Zi-Liang Qiu, Xiang-Bai Sun, Jun-Jie Yang, Si Chen, Chunyang Yi, Xiaolei Chai, Mingyao Liu, Li-Fang Yu^*, Weiqiang Lu^*, Han-Kun Zhang^*.From a Designer Drug to the Discovery of Selective Cannabinoid Type 2 Receptor Agonists with Favorable Pharmacokinetic Profiles for the Treatment of Systemic Sclerosis[J]. Journal of Medicinal Chemistry, 2021 Jan 14;64(1):385-403.

4. Xingwu Jiang^#, Si Chen^#, Qiansen Zhang, Chunyang Yi, Jiacheng He, Xiyun Ye, Mingyao Liu, Weiqiang Lu^*. Celastrol is a novel selective agonist of cannabinoid receptor 2 with anti-inflammatory and anti-fibrotic activity in a mouse model of systemic sclerosis[J]. Phytomedicine.2020, Feb;67:153160.

5. XingWu Jiang^#, BeiEr Jiang^#, Hao Liu, ZhiTao Liu, LongLong Hu, Mingyao Liu, Weiqiang Lu, HanKun Zhang, Design, synthesis, and biological evaluations of phenylpropiolic acid derivatives as novel GPR40 agonists [J].European Journal of Medicinal Chemistry, 2018 Oct 5;158:123-133.

6. Xingwu Jiang^#, Weiqiang Lu^#, Xiaoyang Shen^#, Quan Wang, Jing Lv, Mingyao Liu, Feixiong Cheng^*, Zhongming Zhao^*, Xiufeng Pang^*. Repurposing sertraline sensitizes non–small cell lung cancer cells to erlotinib by inducing autophagy [J]. JCI insight, 2018, 3(11).